Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
NCT00419263 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 344
Last updated 2015-02-12
Summary
This is a study for patients with flu who also have a fever as well as other flu symptoms. Patients must have had symptoms for less than 48 hours in order to participate. Patients will have two out of three chances of getting an active study treatment and the other third will receive a placebo (dummy drug). Nobody will know who gets the active drug and who gets the inactive drug. All patients will get supplies to treat symptoms of flu. Patients will need to be seen 5 more times after they are enrolled in the study.
Conditions
Interventions
- DRUG
-
Peramivir 150 mg
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (one injection of peramivir 150 mg and one injection of placebo).
- DRUG
-
Peramivir 300 mg
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (2 injections of peramivir 150 mg).
- DRUG
-
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (2 injections of placebo).
Sponsors & Collaborators
-
BioCryst Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Stanley Block, MD · Kentucky Pediatric/Adult Research
-
James Borders, MD · Central Kentucky Research Assoc, Inc
-
Robert Broker, MD · Hillcrest Family Practice
-
Paul Browstone, MD · Alpine Clinical Research Center
-
Jeffry Jacqmein, MD · Jacksonville Center For Clinical Research
-
Isaac Marcadis, MD · Palm Beach Research Center
-
Mark Stich, MD · Jacksonville Center For Clinical Research
-
George Atiee, MD · GSA Research
-
Joe Blumenau, MD · Research Across America
-
John Champlin, MD · Medical Center
-
Shane Christensen, MD · J. Lewis Research, Inc. Foothill Family Clinic South
-
Steven Duckor, MD · Advanced Clinical Research Institute
-
Lewis Eirinberg, MD · Midwest Family Physicians
-
Milton K. Erman, MD · Pacific Sleep Medicine Services
-
Stanley Cohen, MD · Radiant Research
-
David L. Fried, MD · Omega Medical Research
-
Yury Furman, MD · Pacific Sleep Medicine Services, Inc.
-
Wayne Harper, MD · Wake Research Associates, LLC
-
Dan C Henry, MD · J. Lewis Research, Inc. Foothill Family Clinic
-
John M. Hill, MD · University Clinical Research-Deland, LLC
-
Veryl Hodges, DO · Clopton Clinic
-
Reuben Holland, III, MD · Clinical Research Center
-
William Jennings, MD · Radiant Research San Antonio
-
James Edmond Kelaher, MD,MPH · Baylor Clinic-Baylor College of Medicine
-
Allan Kelly, MD · Hermitage Medicentres
-
Ben Lasko, MD · Manna Research
-
Mark Leber, MD · The Brooklyn Hospital Center
-
Larissa Lim, MD · Florida Medical Research Institute
-
Alain Martel, MD · Clinique medicale des Campus
-
Dennis Mikolich, MD · Paragon Clinical Research, Inc.
-
Julie Mullen, MD · Sterling Research Group, LTD.
-
David Parenti, MD · George Washington University
-
Monica Pierson, MD · Radiant Research
-
Robert Poirier, MD · Barnes-Jewish Hospital Emergency Department
-
Ivan Rarick, MD · Benchmark Research
-
Dennis Riff, MD · Advanced Clinical Research Institute
-
Q Rizvi, MD · Castledowns Medicentre
-
Michael Rokeach, MD · Pacific Sleep Medicine Services
-
Rawle Seupaul, MD · Wishard Hospital
-
Daniel Shu, MD · Gain Medical Research Centre
-
Steve Sitar, MD · Orange County Clinical Trials
-
Kirk Stiffler, MD · Summa Emergency Associates Inc.
-
Guy Tellier, MD · Omnispec clinical research Inc
-
Michael Warren, MD · Research Across America at Oyster Point Family Health Center
-
Randall Watson, MD · J. Lewis Research, Inc./Southwest Family Medicine
-
John Michael Wise, MD · Bozeman Urgent Care Center
-
Chivers Woodruff, Jr., MD · Radiant Research
-
Bruce Berwald, MD · Radiant Research
-
Frank Maggiacomo, DO · New England Center for Clinical Research, Inc
-
Barry Packman, MD · Radiant Research
-
Sheila Rodstein, MD · Radiant Research, Minneapolis
-
Bernardo Ng, MD · Pacific Sleep Medicines Service
-
Gerardo Losoya, MD · Towngate Plaza Medical Center
-
Francis X. Burch, MD · Radiant Research-San Antonio Northeast
-
John P. Delgado, MD · Integrated Medical Research, PC
-
Edward Fein, MD · Pulmonary & Critical Care Associates
-
Bruce D. Forney, MD · Alliance Medical Center
-
James E. Greenwald, MD · Medex Healthcare Research, Inc.
-
Robert Hudrick, DO · University of Medicine & Dentistry of New Jersey
-
Robert Jeanfreau, MD · Benchmark Research
-
Robert Kaufmann, MD · Georgia Clinical Research
-
Sy Lam, MD · Calgary West Medical Centre Clinical Studies
-
Keith S. Reisinger, MD, MPH · Primary Physicians Research, Inc
-
Keith S. Reisinger, MD, MPH · Family Practice Medical Associates South
-
Earl Martin, MD · Dynamed Clinical Research
-
Jean-Sebastien Gauthier, MD · Q & T Research Inc.
-
Jeffrey Rosen, MD · Clinical Research of Southern Florida
-
Gerald Burns, MD · New Orleans Medical
-
Stewart Behiel, MD · Belvedere Medicentre
-
Giuseppe D'Ignazio, MD · Source Unique Clinic
-
Indravadan Dattani, MD · Prairie Clinical
-
Roy A. Gritter, MD · RJA Medicentres
-
Balbir Chahal, MD · Balbir Chahal M.D. ,P.A.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-09-30
- Completion
- 2007-09-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza
NCT02635724 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
NCT00453999 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
NCT00957996 ·Status: COMPLETED ·Phase: PHASE3
-
Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections
NCT02665351 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
NCT02369159 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
NCT01231620 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
NCT00958776 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
NCT01980966 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza
NCT01056380 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A
NCT04683406 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
NCT01610245 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza
NCT02603952 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
NCT01068912 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)
NCT05818124 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
NCT01314911 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir
NCT00799760 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
NCT02293863 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
NCT05567783 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
NCT02008344 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
NCT01527110 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
NCT01063933 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
NCT01227421 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT02342249 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir
NCT00980109 ·Status: COMPLETED ·Phase: PHASE4
-
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
NCT01728753 ·Status: COMPLETED ·Phase: PHASE1/PHASE2